WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says The World Health Organizations new guidelines recognizing obesity as a disease and suggesting that GLP-1 drugs be part of long-term treatment could have wide-ranging benefits, says Ivania Rizo, a Boston University endocrinologist whose research interests center on obesity, diabetes, and metabolic disorders
These drugs slow gastric emptying, raising concerns about pulmonary aspiration during anaesthesia
doi: 10.1038/s41598-022-08840-7 89 MiaoyuL.LeileiY.JianxinZ.HaoZ.WeiC.QixiaoZ.et al
One of the things I appreciate most about working at Empower Pharmacy is that I have access to many of our innovative wellness and skincare products as part of my employee benefits package completely free of charge
VERIFICATION STANDARD
If approved, Wegovy will become the first oral GLP-1 indicated for chronic weight management
